|
gptkbp:instanceOf
|
Controlled substance category
|
|
gptkbp:application
|
Drugs can be added, removed, or transferred between schedules by the DEA with input from the FDA
|
|
gptkbp:cannotBePrescribed
|
True
|
|
gptkbp:contrastsWith
|
gptkb:Schedule_II_drugs
|
|
gptkbp:country
|
gptkb:United_States
|
|
gptkbp:criteria
|
High potential for abuse
Lack of accepted safety for use under medical supervision
No currently accepted medical use in treatment in the US
|
|
gptkbp:definedIn
|
gptkb:United_States_Controlled_Substances_Act
|
|
gptkbp:example
|
gptkb:Heroin
gptkb:Methaqualone
gptkb:Psilocybin
gptkb:MDMA_(Ecstasy)
gptkb:Marijuana_(cannabis)
LSD
Peyote
Bath salts (synthetic cathinones)
GHB (when not used for medical purposes)
Khat
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Schedule I drugs
|
|
gptkbp:legalStatus
|
Illegal to possess, manufacture, or distribute in the US
|
|
gptkbp:managedBy
|
gptkb:Drug_Enforcement_Administration_(DEA)
|
|
gptkbp:penalty
|
Severe federal criminal penalties for violations
|
|
gptkbp:relatedTo
|
gptkb:21_U.S.C._§_812
List of Schedule I drugs (DEA)
|
|
gptkbp:scheduleNumber
|
I
|
|
gptkbp:bfsParent
|
gptkb:Title_II:_Controlled_Substances_Act
gptkb:Controlled_Substances_Act_(US)
|
|
gptkbp:bfsLayer
|
7
|